Pirfenidone drug page Clinical trials

Trials with Pirfenidone

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
1Recruiting
1Countries
55Planned patients

Showing 1–2 of 2

Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
Recruiting Phase 2 25 patients NCT06484153

The purpose of this study is to evaluate the efficacy and safety of fruquintinib and pirfenidone in combination with anti-PD-1 antibody in patients with standard treatment failure of advanced or metastatic pMMR/MSS colorectal adenocarcinom…

China Jul 2024 – Dec 2026 Interventional
A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Chemotherapy for Colorectal Cancer Patients With Peritoneal Metastasis.
Not yet recruiting Phase 2 30 patients NCT07268677

Assuming that the objective response rate (ORR) of neoadjuvant chemotherapy in patients with colorectal cancer peritoneal metastasis is approximately 0.40 , a total sample size of 30 patients is required. Step 1: Ten patients will be ini…

Dec 2025 – Feb 2027 Interventional

Where the recruiting trials are